Xencor logo

Xencor Share Price Today

(NASDAQ: XNCR)

Xencor share price is $10.84 & ₹924.89 as on 25 Apr 2025, 2.30 'hrs' IST

$10.84

-0.03

(-0.28%)

Market is closed - opens 7 PM, 25 Apr 2025

View live Xencor share price in Dollar and Rupees. Guide to invest in Xencor stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xencor, along with analyst recommendations, forecasts, and comprehensive financials.

Xencor share price movements

  • Today's Low: $10.40
    Today's High: $10.92

    Day's Volatility :4.76%

  • 52 Weeks Low: $7.16
    52 Weeks High: $27.24

    52 Weeks Volatility :73.72%

Xencor (XNCR) Returns

PeriodXencor IncSector (Health Care)Index (Russel 2000)
3 Months
-44.73%
-6.0%
0.0%
6 Months
-48.68%
-8.7%
0.0%
1 Year
-43.53%
-3.1%
0.0%
3 Years
-58.23%
0.8%
-9.5%

Xencor (XNCR) Key Statistics

in dollars & INR

Previous Close
$10.87
Open
$10.82
Today's High
$10.92
Today's Low
$10.4005
Market Capitalization
$746.9M
Today's Volume
$1.4M
52 Week High
$27.24
52 Week Low
$7.16
Revenue TTM
$110.5M
EBITDA
$-164.0M
Earnings Per Share (EPS)
$-3.58
Profit Margin
-210.53%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-35.41%

How to invest in Xencor Stock (XNCR) from India?

It is very easy for Indian residents to invest directly in Xencor from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xencor stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xencor or XNCR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xencor or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xencor shares which would translate to 0.079 fractional shares of Xencor as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xencor, in just a few clicks!

Returns in Xencor (XNCR) for Indian investors in Rupees

The Xencor stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xencor investment value today

Current value as on today

₹58,783

Returns

₹41,217

(-41.22%)

Returns from Xencor Stock

₹43,630 (-43.63%)

Dollar Returns

₹2,413 (+2.41%)

Indian investors sentiment towards Xencor (XNCR)

-13%

Period: Mar 25, 2025 to Apr 24, 2025. Change in 30 Days versus previous period

Search interest for Xencor Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Xencor

  • BlackRock Inc

    17.32%

  • PRIMECAP Management Company

    12.75%

  • Vanguard Group Inc

    11.38%

  • EcoR1 Capital, LLC

    8.72%

  • T. Rowe Price Associates, Inc.

    5.73%

  • State Street Corp

    4.54%

Analyst Recommendation on Xencor

Rating
Trend

Buy

    84%Buy

    10%Hold

    5%Sell

Based on 19 Wall street analysts offering stock ratings for Xencor(by analysts ranked 0 to 5 stars)

Analyst Forecast on Xencor Stock (XNCR)

What analysts predicted

Upside of 179.52%

Target:

$30.30

Current:

$10.84

Insights on Xencor Stock (Ticker Symbol: XNCR)

  • Price Movement

    In the last 7 days, XNCR stock has moved up by 12.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 10.71M → 70.01M (in $), with an average increase of 84.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -45.14M → -53.47M (in $), with an average decrease of 18.5% per quarter
  • XNCR vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 68.7% return, outperforming this stock by 112.2%
  • XNCR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 54.0% return, outperforming this stock by 113.3%
  • Price to Sales

    ForXNCR every $1 of sales, investors are willing to pay $6.4, whereas for Beone Medicines Ltd, the investors are paying $7.1 for every $1 of sales.

Xencor Technicals Summary

Sell

Neutral

Buy

Xencor is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Xencor (XNCR) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Xencor Inc logo
-8.12%
-48.68%
-43.53%
-58.23%
-65.14%
Regeneron Pharmaceuticals, Inc. logo
-8.15%
-36.99%
-33.99%
-12.87%
7.38%
Beone Medicines Ltd logo
-0.1%
17.79%
68.73%
64.3%
51.92%
Vertex Pharmaceuticals Incorporated logo
-1.59%
3.06%
23.79%
83.91%
83.35%
Alnylam Pharmaceuticals, Inc. logo
-9.98%
-14.92%
68.63%
56.35%
69.83%

About Xencor

Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis, neuromyelitis optica spectrum disororder; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma; and Sotrovimab that targets the SARS-CoV-2 virus. It develops XmAb819, a bispecific antibody to treat renal cell carcinoma; XmAb541, which is in Phase I for the treatment of ovarian cancer; XmAb808, a bispecific antibody that binds to the broadly expressed tumor antigen; Vudalimab, which is in Phase II clinical trial to treat metastatic castration-resistant prostate cancer; XmAb564, to treat autoimmune diseases; XmAb662, which is in Phase I clinical trial to treat patients with solid tumors; XmAb942, which is in Phase I clinical trial for patients with Crohn's disease and ulcerative colitis; and Plamotamab, a bispecific antibody, which is in Phase I clinical trial to treat lymphoma. Further, the company develops Xaluritamig, a bispecific T-cell engager that treats prostate cancer; Obexelimab, to treat patients with immunoglobulin G4-related disease; Teropavimab and zinlirvimab to treat human immunodeficiency virus; Tobevibart, a treatment for hepatitis Delta virus infection; Novartis, an antibody drug candidate that uses XmAb Fc technologies; Xpro1595 to treat patients with Alzheimer's disease and treatment-resistant depression; Zaltenibart to treat paroxysmal nocturnal hemoglobinuria and other alternative pathway disorders; ASP2138 to treat gastric, gastroesophageal junction, and pancreatic cancers; JNJ-9401 to treat prostate cancer; and JNJ-1493 to treat B-cell malignancies. The company was incorporated in 1997 and is headquartered in Pasadena, California.
Organization
Xencor
Employees
250
CEO
Dr. Bassil I. Dahiyat Ph.D.
Industry
Health Technology

Management People of Xencor

NameTitle
Dr. Bassil I. Dahiyat Ph.D.
Co-Founder, CEO, President & Director
Dr. John R. Desjarlais Ph.D.
Executive VP of Research & Chief Scientific Officer
Ms. Celia E. Eckert J.D.
Senior VP, General Counsel & Corporate Secretary
Dr. Nancy Valente M.D.
Executive VP & Chief Development Officer
Mr. Bart Jan Cornelissen
Senior VP & CFO
Mr. Charles Liles
Associate Director and Head of Corporate Communications & Investor Relations
Ms. Jennifer Sandoz
Senior VIce President of Human Resources
Dr. Jeremy Grunstein Ph.D.
Senior Vice President of Business Development
Mr. Kirk Rosemark RAC
Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. Eric P. Kowack
Senior Vice President of Program Leadership & Alliance Management

Important FAQs about investing in XNCR Stock from India :

What is Xencor share price today?

Xencor share price today stands at $10.84, Open: $10.82 ; Previous Close: $10.87 ; High: $10.92 ; Low: $10.40 ; 52 Week High: $27.24 ; 52 Week Low: $7.16.

The stock opens at $10.82, after a previous close of $10.87. The stock reached a daily high of $10.92 and a low of $10.40, with a 52-week high of $27.24 and a 52-week low of $7.16.

Can Indians buy Xencor shares?

Yes, Indians can invest in the Xencor (XNCR) from India.

With INDmoney, you can buy Xencor at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Xencor at zero transaction cost.

How can I buy Xencor shares from India?

It is very easy to buy Xencor from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xencor (XNCR) be purchased?

Yes, you can buy fractional shares of Xencor with INDmoney app.

What are the documents required to start investing in Xencor stocks?

To start investing in Xencor, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Xencor Stock (XNCR)?

Today’s highest price of Xencor (XNCR) is $10.92.

Today’s lowest price of Xencor (XNCR) is $10.40.

What is today's market capitalisation of Xencor?

Today's market capitalisation of Xencor XNCR is 746.9M

What is the 52 Week High and Low Range of Xencor Stock (XNCR)?

  • 52 Week High

    $27.24

  • 52 Week Low

    $7.16

What are the historical returns of Xencor (XNCR)?

  • 1 Month Returns

    -8.12%

  • 3 Months Returns

    -48.68%

  • 1 Year Returns

    -43.53%

  • 5 Years Returns

    -65.14%

Who is the Chief Executive Officer (CEO) of Xencor ?

Dr. Bassil I. Dahiyat Ph.D. is the current Chief Executive Officer (CEO) of Xencor.